Department of Animal Science, Texas A&M University, College Station, Texas 77843-2471, USA.
J Food Prot. 2013 Jan;76(1):124-8. doi: 10.4315/0362-028X.JFP-12-277.
Escherichia albertii is an emerging gram-negative facultative rod that has been implicated in multiple cases of human diarrheal disease, particularly in young children. When biochemical and other typing methods have been used, this organism has often been misidentified due to similarities with other members of the family Enterobacteriaceae. Isolates have been reported to be capable of producing attachment and effacement lesions via the synthesis of intimin, cytolethal distending toxin, and a variant form of Shiga toxin. The purposes of this study were to characterize the antibiotic resistance characteristics and the growth of individual strains of E. albertii on raw ground beef at different storage temperatures. Nalidixic acid-resistant strains of E. albertii were inoculated onto raw ground beef to a target of 4.0 log CFU/g, and samples were then aerobically incubated at 5, 22, or 35°C for various time periods prior to microbiological enumeration of the pathogen on lactose-free MacConkey agar containing 50 mg of nalidixic acid per liter and 0.5% L-rhamnose. Antibiotic resistance was determined using a broth microdilution assay. E. albertii did not grow at 5°C, with populations declining slowly over 14 days of refrigerated storage. Strains of the organism grew well under abusive storage, increasing by 2.5 to 3.1 log CFU/g and 4.1 to 4.3 log CFU/g after 24 h at 22 and 35°C, respectively. All strains were resistant to tetracycline but were sensitive to tested cephalosporins and chloramphenicol. Resistance to penicillin was observed, but susceptibility to other members of the b -lactam group, including ampicillin, amoxicillin, and clavulanic acid, was recorded. E. albertii represents an emerging pathogen with a probable foodborne transmission route. Future research should focus on verifying food process measures able to inactivate the pathogen.
产酸克雷伯氏菌是一种新出现的革兰氏阴性兼性杆菌,已被牵连到多个人类腹泻病病例中,尤其是在幼儿中。当使用生化和其他分型方法时,由于与肠杆菌科的其他成员相似,这种生物体经常被错误识别。据报道,分离株能够通过合成紧密素、细胞致死性扩张毒素和志贺毒素的变体形式产生附着和破坏病变。本研究的目的是表征产酸克雷伯氏菌的抗生素耐药特性和在不同储存温度下生绞碎牛肉上的单个菌株的生长情况。将耐萘啶酸的产酸克雷伯氏菌菌株接种到生绞碎牛肉中,目标为 4.0 log CFU/g,然后在 5、22 或 35°C 下有氧孵育,在含有 50 mg 萘啶酸/升和 0.5% L-鼠李糖的乳糖无麦康凯琼脂上对病原体进行微生物计数之前,进行不同时间的培养。使用肉汤微量稀释法测定抗生素耐药性。产酸克雷伯氏菌在 5°C 下不生长,在冷藏储存 14 天期间缓慢减少。该生物体的菌株在恶劣的储存条件下生长良好,在 22 和 35°C 下分别培养 24 小时后,其数量增加了 2.5 至 3.1 log CFU/g 和 4.1 至 4.3 log CFU/g。所有菌株均对四环素耐药,但对测试的头孢菌素和氯霉素敏感。观察到对青霉素的耐药性,但对包括氨苄西林、阿莫西林和克拉维酸在内的β-内酰胺组的其他成员具有敏感性。产酸克雷伯氏菌是一种新出现的病原体,可能通过食物传播。未来的研究应集中于验证能够使病原体失活的食品加工措施。